Q1 2026 Holdings
Filed 2026-05-15 | 41 holdings | $478.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $47.0M | 560,308 | 9.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $32.1M | 432,014 | 6.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $29.5M | 129,111 | 6.2% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $25.5M | 420,727 | 5.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $24.4M | 1,043,670 | 5.1% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $22.8M | 163,905 | 4.8% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $21.6M | 409,031 | 4.5% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $19.6M | 1,037,984 | 4.1% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $19.3M | 577,808 | 4.0% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $18.8M | 299,318 | 3.9% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $17.8M | 850,797 | 3.7% |
| Incyte Corp(INCY) | COM | 45337C102 | $17.1M | 182,101 | 3.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $14.2M | 215,501 | 3.0% |
| Natera Inc(NTRA) | COM | 632307104 | $14.2M | 70,907 | 3.0% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $13.0M | 891,933 | 2.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $12.3M | 255,379 | 2.6% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $11.9M | 439,041 | 2.5% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $11.6M | 144,607 | 2.4% |
| Veradermics Inc(MANE) | COMMON STOCK | 922967104 | $11.0M | 173,582 | 2.3% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $10.0M | 722,784 | 2.1% |
| Heartflow Inc(HTFL) | COM | 42238D107 | $9.8M | 403,588 | 2.1% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $8.6M | 426,551 | 1.8% |
| Uniqure NV(QURE) | SHS | N90064101 | $8.0M | 491,116 | 1.7% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $7.9M | 122,978 | 1.6% |
| Septerna Inc(SEPN) | COM | 81734D104 | $7.1M | 294,360 | 1.5% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $5.3M | 47,193 | 1.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $5.1M | 282,954 | 1.1% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $5.1M | 1,639,816 | 1.1% |
| Karyopharm Therapeutics Inc(KPTI) | COM NEW | 48576U205 | $5.0M | 897,709 | 1.0% |
| Supernus Pharmaceuticals(SUPN) | COM | 868459108 | $3.2M | 62,019 | 0.7% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $3.0M | 580,024 | 0.6% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $2.8M | 247,767 | 0.6% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $2.7M | 83,554 | 0.6% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $2.6M | 67,285 | 0.5% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $2.5M | 84,352 | 0.5% |
| Fractyl Health Inc(GUTS) | COM | 35168W103 | $2.5M | 5,491,866 | 0.5% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $1.4M | 1,320,041 | 0.3% |
| Metagenomi Therapeutics Inc(MGX) | COM | 59102M104 | $708.9K | 528,993 | 0.1% |
| Ataibeckley Inc(ATAI) | COM SHS | 04650F101 | $696.9K | 196,858 | 0.1% |
| Sensei Biotherapeutics Inc(SNSE) | COM NEW | 81728A207 | $463.9K | 14,718 | 0.1% |
| Outset MED Inc(OM) | COM NEW | 690145206 | $454.2K | 118,279 | 0.1% |